Fleury S.A. (BVMF:FLRY3)
Brazil · Delayed Price · Currency is BRL 16.83
-0.23 (-1.35%)
Jul 29, 2026, 5:05 PM GMT-3
Fleury Financials Overview
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,499 | 8,291 | 7,685 | 6,471 | 4,463 | 3,873 |
Revenue Growth | 9.03% | 7.89% | 18.76% | 44.99% | 15.25% | 30.32% |
Gross Profit Gross Profit Growth | 2,262 | 2,206 | 2,143 | 1,740 | 1,210 | 1,127 |
Operating Income Operating Income Growth | 1,287 | 1,253 | 1,238 | 929.77 | 740.95 | 652.33 |
Net Income Net Income Growth | 634.76 | 612.83 | 616.17 | 423.76 | 307.91 | 349.93 |
Earnings Per Share EPS Growth | 1.16 | 1.12 | 1.13 | 0.87 | 0.91 | 1.05 |
EPS Growth | 1.34% | -0.50% | 29.22% | -3.72% | -13.28% | 36.94% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Diagnostic Medicine Diagnostic Medicine Growth | 5,995 | 5,781 | 5,217 | 4,555 | 3,505 | 3,025 |
Integrated Medicine Integrated Medicine Growth | 2,504 | 2,510 | 2,467 | 1,916 | 958.44 | 847.41 |
Total Total Growth | 8,499 | 8,291 | 7,685 | 6,471 | 4,463 | 3,873 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,150 | 2,162 | 2,342 | 924.13 | 1,309 | 797.09 |
Total Debt Total Debt Growth | 5,357 | 5,271 | 5,392 | 4,241 | 3,678 | 2,949 |
Net Cash (Debt) Net Cash Growth | -3,207 | -3,109 | -3,050 | -3,317 | -2,369 | -2,152 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.88 | -5.71 | -5.59 | -6.85 | -6.99 | -6.44 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,076 | 2,134 | 1,930 | 1,439 | 987.13 | 1,019 |
Capital Expenditures CapEx Growth | -265.98 | -260.59 | -263.63 | -413.81 | -258.2 | -413.29 |
Free Cash Flow Free Cash Flow Growth | 1,810 | 1,873 | 1,667 | 1,025 | 728.94 | 605.38 |
Free Cash Flow Growth | 2.12% | 12.38% | 62.54% | 40.68% | 20.41% | 31.80% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 26.61% | 26.61% | 27.89% | 26.89% | 27.11% | 29.10% |
Operating Margin | 15.14% | 15.11% | 16.11% | 14.37% | 16.60% | 16.84% |
Pretax Margin | 9.13% | 9.08% | 10.23% | 8.21% | 9.08% | 12.81% |
Profit Margin | 7.47% | 7.39% | 8.02% | 6.55% | 6.90% | 9.04% |
FCF Margin | 21.30% | 22.59% | 21.69% | 15.85% | 16.33% | 15.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.209 | 1.209 | 1.017 | 0.582 | - | 1.023 |
Dividend Per Share Growth | 139.70% | 18.85% | 74.69% | - | - | 47.30% |
Dividend Yield | 7.09% | 8.06% | 9.51% | 3.82% | - | 7.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.45 | 13.34 | 10.66 | 23.28 | 18.39 | 16.30 |
Forward PE | 11.84 | 13.05 | 8.94 | 15.24 | 14.93 | 19.57 |
P/FCF Ratio | 5.05 | 4.36 | 3.94 | 9.62 | 7.77 | 9.42 |
PS Ratio | 1.08 | 0.99 | 0.86 | 1.52 | 1.27 | 1.47 |